Document

Gastroparesis: Clinical Evaluation of Drugs for Treatment; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Gastroparesis: Clinical Evaluation of Drugs for Treat...

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled ``Gastroparesis: Clinical Evaluation of Drugs for Treatment.'' This draft guidance is intended to provide FDA's current thinking regarding clinical trial design and clinical endpoint assessments to support development of drugs for the treatment of diabetic and idiopathic gastroparesis.

Legal Citation

Federal Register Citation

Use this for formal legal and research references to the published document.

80 FR 43781

Web Citation

Suggested Web Citation

Use this when citing the archival web version of the document.

“Gastroparesis: Clinical Evaluation of Drugs for Treatment; Draft Guidance for Industry; Availability,” thefederalregister.org (July 23, 2015), https://thefederalregister.org/documents/2015-18023/gastroparesis-clinical-evaluation-of-drugs-for-treatment-draft-guidance-for-industry-availability.